Aktivnosti Službe za razvoj, istraživanje i zdravstvene tehnologije rezultirale su ovim znanstvenim i stručnim publikacijama (kronološki):
- Kalo Z, Csanadi M, Vitezic D, Huic M, Husereau D, Kristensen FB. Comparison of current and preferred status of hta implementation in central and eastern europen countries. Value Health. 2015 Nov;18(7):A538.
- Guegan EW, Huić M, Teljeur C. EUnetHTA: further steps towards European cooperation on health technology assessment. Int J Technol Assess Health Care. 2014 Nov;30(5):475-7.
- Kleijnen S, Toenders W, de Groot F, Huic M, George E, Wieseler B, Pavlovic M, Bucsics A, Siviero PD, van der Graaff M, Rdzany R, Kristensen FB, Goettsch W. European collaboration on relative effectiveness assessments: What is needed to be successful? Health Policy. 2015 May;119(5):569-76.
- Pokhrel S, Evers S, Leidl R, Trapero-Bertran M, Kalo Z, Vries Hd, Crossfield A, Andrews F, Rutter A, Coyle K, Lester-George A, West R, Owen L, Jones T, Vogl M, Radu-Loghin C, Voko Z, Huic M, Coyle D. EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control. BMJ Open. 2014 Nov 24;4(11):e006945.
- Zechmeister-Koss I, Huić M, Fischer S; for the European Network for Health Technology Assessment (EUnetHTA). The Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review. Obes Surg. 2013 Nov 30. [Epub ahead of print]
- Huić M, Nachtnebel A, Zechmeister I, Pasternak I, Wild C. COLLABORATION IN HEALTH TECHNOLOGY ASSESSMENT (EUnetHTA JOINT ACTION, 2010-2012): FOUR CASE STUDIES. Int J Technol Assess Health Care. 2013;12:1-8.
- Eikermann M, Gluud C, Perleth M, Wild C, Sauerland S, Gutierrez-Ibarluzea I, Antoine SL, Demotes-Mainard J, Neugebauer EA; Signatories of Our Open Letter to the European Union.Commentary: Europe needs a central, transparent, and evidence based regulation process for devices. BMJ. 2013;7;346:f2771.
- Hulstaert F, Neyt M, Vinck I, Stordeur S, Huić M, Sauerland S, i sur. Pre-market Clinical Evaluations of Innovative High-Risk Medical Devices in Europe. Int J Technol Assess Health Care. 2012;28: 278–284.
- Zechmeister-Koss I, Huic M. Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review. Br J Ophthalmol. 2011; doi:10.1136/bjophthalmol-2011-300674.
- Huić M, Marušić M, Marušić A. Completeness and Changes in Registered Data and Reporting Bias of Randomized Controlled Trials in ICMJE Journals after Trial Registration Policy. PLoS ONE. 2011; 6(9): e25258. doi:10.1371/journal.pone.0025258
- Huić M. Procjena zdravstvenih tehnologija u Hrvatskoj: uloga Agencije za kvalitetu i akreditaciju u zdravstvu. HČJZ. 2011;7:e.
- Mittermayer R, Huić M, Meštrović J. Kvaliteta zdravstvene zaštite, akreditacija nositelja zdravstvene djelatnosti i procjena zdravstvenih tehnologija u Hrvatskoj: uloga Agencije za kvalitetu i akreditaciju u zdravstvu. Acta Med Croatica. 2011;64:425-34
- Huić M. Procjena zdravstvenih tehnologija u Hrvatskoj. Glasnik Medicinskog fakulteta u Splitu. 2011;4:48-9.
- Huić M. Procjena zdravstvenih tehnologija (engl.Health Technology Assessment, HTA) u Hrvatskoj. Lijecnicke novine, 2010.
- Bobinac A. Ekonomske analize kao dio procesa procjene zdravstvenih tehnologija. Lijecnicke novine, 2010.